Diane S. Aschenbrenner
* Warnings in the labeling of all fluoroquinolone antibiotics have been strengthened to more effectively alert providers to the risk of peripheral neuropathy with systemic use of these drugs.
* Topical preparations for the eye and ear don't share this risk.
* Peripheral neuropathy can result quickly after initiating therapy with a fluoroquinolone and can be permanent.